Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome injection for postoperative pain after minimally invasive cardiac surgery
ChiCTR2500107741Phase 4Not yet recruiting
- Sponsor
- Fuwai Central China Cardiovascular Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Fuwai Central China Cardiovascular Hospital. Primary endpoint: Resting NRS pain score at 24 hours after surgery. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500107741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107741.